EcoR1 Capital, LLC: 13F holdings
CIK 15871142026Q2
| Positions | 31 |
|---|
| Reported value | $2.1bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 31 (+2 vs prior quarter) |
|---|
| Reported value | $2.1bn (-12.7%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| ZYME ZYMEWORKS INC | 22,970,388 | $600.4m | 29.2% |
| ANAB ANAPTYSBIO INC | 7,880,094 | $531.9m | 25.9% |
| AKTIS ONCOLOGY INC | 4,824,469 | $155.5m | 7.6% |
| CGON CG ONCOLOGY INC | 1,494,300 | $106.2m | 5.2% |
| ETON ETON PHARMACEUTICALS INC | 2,171,938 | $78.6m | 3.8% |
| CRISPR THERAPEUTICS AG | 1,389,276 | $75.8m | 3.7% |
| ORIC ORIC PHARMACEUTICALS INC | 6,728,116 | $72.9m | 3.5% |
| FIRST TRACKS BIOTHERAPEUTICS | 3,174,519 | $63.9m | 3.1% |
| LKFT LAKEFRONT BIOTHERAPEUTICS NV | 1,667,119 | $50.0m | 2.4% |
| NGNE NEUROGENE INC | 1,271,342 | $40.0m | 1.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1587114")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples